It has been announced by pharmaceutical company, Biogen, that Alzheimer’s drug aducanumab (commercially known as Aduhelm) will be withdrawn from use by November 2024. Biogen say this isn’t due to any safety or efficacy concerns. Aducanumab was offered to people living with Alzheimer’s in the US from June 2021, but was not approved for use…
The National Institute for Health and Care Research (NIHR) Policy Research Unit are looking for people with dementia (of any type) to join their Policy Research Unit to help shape their work. Involvement opportunities are varied and participants are paid for their time. You can find out more by contacting Rachael Litherland from Innovations in…
Alzheimer’s Disease International (ADI) has announced its participation in and launch of the AD-RIDDLE project. The project is a collaboration between academics, healthcare providers, pharmaceutical and diagnostic companies, regulatory bodies and patient advocacy organisations. It aims to improve detection, diagnosis and prevention of Alzheimer’s disease and, whilst initially focused on European countries, it’s hoped it…
Labour has announced plans for a life sciences sector strategy, with an emphasis on clinical trial participation to help find new treatments for conditions including Alzheimer’s disease. The plan would include establishing standing national registries for clinical trials, boosting public participation in clinical trials, and making better use of data. You can find out more…
The Alzheimer’s Society have opened their funding rounds for researchers to obtain grants. You can find out more here https://alzheimers.org.uk/research/researchers/grants and apply through the Alzheimer’s Society portal here: https://grants.alzheimers.org.uk The deadline for applications is 22 March 2024.
The Royal College of Speech and Language Therapists, Rare Dementia Support, and Dyscover have called on the Government and NHS England to reinstate the National Hospital for Neurology and Neurosurgery (NHNN)’s speech and language therapy (SLT) service, which closed in 2023. In their letter to the Secretary of State for Health and Social Care,…
Wellcome, a charitable foundation focused on health research, has announced a targeted funding programme for researchers of Black, Bangladeshi and Pakistani heritage in the UK to stay in research and advance their careers. From their data and insight work Wellcome have identified these groups as underrepresented, and they are keen to encourage the diversity of…
The Alzheimer’s Society have shared information on their research plans for 2024. These include: More investment in dementia research Progress with the Blood Biomarker Challenge (find out more about the Blood Biomarker Challenge here: https://journalofdementiacare.co.uk/blood-biomarker-challenge-for-dementia-diagnosis) Work on new Alzheimer’s disease drug approval A research nurses project Combatting inequalities around dementia Progress with the Longitude Prize…
The Dementia Translational Collaboration Trials Network, an initiative run by The National Institute for Health and Care Research (NIHR), has received £49.9 million in government funding to set up new dementia research sites across the UK to enable more people to take part in early phase clinical trials. The Dementia Translational Collaboration Trials Network will…
Alzheimer’s Society are looking for an experienced dementia researcher who wants to achieve research independence with their Dementia Research Leader Fellowship. The successful applicant will need to have several years of proven research ability behind them, and the ambition and skill to conduct excellent quality and innovative research, build a positive research culture, and drive…